Indicator summary: Bearish (0 bullish, 4 bearish, 1 neutral). As of 2026-11-05, the close was $514.20: 12.3% below the 50-day average and 22.1% below the 200-day average, which is rising. RSI (14) is 33, in its neutral range. MACD is bearish. The stock sits 2% of the way up its 52-week range of $500.23 to $1,096.68, on 1.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $586.61 | Price 12.3% below |
| 200-day average | $660.32 | Price 22.1% below, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 33 | Neutral range |
| MACD (12, 26, 9) | -13.58 vs -4.29 | Line below signal |
| 52-week range | $500.23 to $1,096.68 | 2% of the way up the range |
| Volume vs 20-day average | 1.5x | Heavy |
Base rates use UI's own daily history since 2011; they describe the past, not a forecast.
As of 2026-11-05, UI's 14-day RSI is 33, which is in the neutral range between 30 and 70.
No. UI closed at $514.20 on 2026-11-05, 22.1% below its 200-day average of $660.32, which is rising. When it closed below its 200-day average (1,227 days), it was higher 63 trading days later 62% of the time, median +5.0%.
No. UI closed at $514.20 on 2026-11-05, 12.3% below its 50-day average of $586.61. When it closed below its 50-day average (1,482 days), it was higher 63 trading days later 63% of the time, median +6.5%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is -13.58 against a signal line of -4.29, so MACD is bearish.
No. At $514.20 it sits 2% of the way up its 52-week range of $500.23 to $1,096.68, 53.1% below the high.
Bearish: 0 of 5 indicators are bullish and 4 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
UI analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.